ADVERTISING MATERIAL
The material contained on this Web site is provided for informational purposes only and does not constitute legal advice. The publication and receipt of any information contained on this Web site does not create an attorney-client relationship with Barash Law LLC or with any of our attorneys. Readers should not act upon any information on this site without seeking professional legal counsel. While the information on this Web site is maintained and periodically updated for accuracy, this information may contain omissions or errors for which we disclaim any and all liability.
Barash Law LLC does not collect identifying information from visitors to its Web site unless the information is provided by the visitor or the visitor's internet browser. We will only respond to direct inquiries, and will use information collected from internet browsers for the sole purpose of monitoring Web site usage. We do not share Web site data with outside third-parties. Barash Law LLC is not responsible for the privacy practices or content of any links to other Web sites contained in our Firm’s Web site.
If you have any questions or concerns regarding this Privacy Statement, please contact us at info@ebarashlaw.com
Drug repositioning traditionally deploys new formulations or methods of treatment to protect the repositioned intellectual property estate. However, there are circumstances where it is possible to get an additional of matter patent for the repositioned asset, namely, by using a solid form patent strategy. This article discusses the theory and practice behind using solid form patents to start a new composition of matter clock and how this strategy has been deployed in practice.
Eyal Barash of Barash Law LLC will be presenting a webinar series through the San Diego Innovation Council this fall. The first webinar will introduce the science behind pharmaceutical solid forms, how they are protected as valuable intellectual property, and why they are important. The second will dive deeper into this topic into solid-form IP, focusing on patentability, claim drafting and interpretation, and infringement in the United States with elements of European practice. Each webinar will include a follow-up interactive Q&A session where Eyal will address any questions and/or comments participants may have.
More information coming soon.
More information coming soon.